Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02856750 · ClinicalTrials.gov registry record · Early Phase 1
Efficacy of Gabapentin vs. Placebo for Adjuvant Pain Control Following Acute Rib Fractures
A Early Phase 1 study of Acute Pain, sponsored by Denver Health and Hospital Authority.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT02856750: Completed Early Phase 1 study of Acute Pain, sponsored by Denver Health and Hospital Authority.
NCT02856750 is a Early Phase 1 study of Acute Pain that has completed, run by Denver Health and Hospital Authority. The registered enrollment target is 100 participants, below the 266-participant average among 50 other Acute Pain trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02856750, a Early Phase 1 study of Acute Pain, has completed, sponsored by Denver Health and Hospital Authority.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
A Multi-center, Randomized Controlled Trial of the Efficacy of Gabapentin vs. Placebo for Adjutant Pain Control Following Acute Rib Fractures.
Primary Outcome
the pain score uses the visual analog scale and ranges from 0 to 10. This is recorded by nursing at pre-specified intervals depending on level of care.
Conditions Studied
Interventions
- DRUG Gabapentin
Study Locations (1)
Colorado
- Denver Health Medical Center - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2016-10 |
| Est. Completion | 2018-10-23 |
| Phase | Early Phase 1 |
What the finished NCT02856750 record still lists
NCT02856750 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 266-participant average among 50 other Acute Pain trials with a reported enrollment target (62% lower).
The record links to 1 condition, with Acute Pain appearing as the primary indexed condition, and to 1 intervention - of which Gabapentin is the first listed.
NCT02856750 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT02856750 about?
NCT02856750 is a clinical study titled "Efficacy of Gabapentin vs. Placebo for Adjuvant Pain Control Following Acute Rib Fractures". A Multi-center, Randomized Controlled Trial of the Efficacy of Gabapentin vs. Placebo for Adjutant Pain Control Following Acute Rib Fractures.
What is the current status of trial NCT02856750?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 100 participants. The study started on 2016-10. Estimated completion is 2018-10-23.
What conditions does trial NCT02856750 study?
This clinical trial studies the following conditions: Acute Pain.
What interventions are being tested in trial NCT02856750?
The interventions under investigation include: Gabapentin (DRUG).
Who is sponsoring clinical trial NCT02856750?
This trial is sponsored by Denver Health and Hospital Authority, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02856750 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02856750's enrollment target sits among peer trials
100 27th of 50 higher than 22 of 50 other Acute Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Testosterone on Experimental Pain Perception
COMPLETED · Early Phase 1
-
Characterization of Acute Pain
RECRUITING
-
Understanding the Acute Pain Phenotype in Patients Undergoing Surgery
RECRUITING
-
Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
RECRUITING
-
Reducing Pain From Wisdom Molar Extractions
RECRUITING · Phase 2
-
Twin Block, Pain Medications and Third Molar Extractions
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia